Similar articles

• High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.

  Freedman AS, Neuberg D, Gribben JG, Mauch P, Soiffer RJ, Fisher DC, Anderson KC, Andersen N, Schlossman R, Kroon M, Ritz J, Aster J, Nadler LM. Freedman AS, et al. J Clin Oncol. 1998 Jan;16(1):13-8. doi: 10.1200/JCO.1998.16.1.13. J Clin Oncol. 1998. PMID: 9440717
• [High-dose chemotherapy with bone marrow transplantation in recurrent or refractory NHL].

  Torello E, Koziner B. Torello E, et al. Sangre (Barc). 1993 Dec;38(6):473-80. Sangre (Barc). 1993. PMID: 7909622 Review. Spanish. No abstract available.
• [Intensive therapy in non-Hodgkins lymphoma. Indications and modalities].

  Albin N, Bemba M, Gabarre J, Sutton L, Leblond V. Albin N, et al. Presse Med. 1998 Jun 6;27(20):977-85. Presse Med. 1998. PMID: 9767846 Review. French. No abstract available.
• Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.

  Colombat P, Cornillet P, Deconinck E, Tourani JM, Gardembas M, Delain M, Abgrall JF, Kootz C, Milpied N. Colombat P, et al. Bone Marrow Transplant. 2000 Nov;26(9):971-7. doi: 10.1038/sj.bmt.1702631. Bone Marrow Transplant. 2000. PMID: 11100276 Clinical Trial.
• The role of hematopoietic stem cell transplantation in non-Hodgkin lymphoma.

  Villanueva ML, Vose JM. Villanueva ML, et al. Clin Adv Hematol Oncol. 2006 Jul;4(7):521-30. Clin Adv Hematol Oncol. 2006. PMID: 17147239 Review.